Hepakind 450mg Tablet contains Ursodeoxycholic Acid 450mg, a hydrophilic bile acid used primarily in the treatment of various hepatobiliary disorders. Ursodeoxycholic Acid acts by reducing the cholesterol content of bile, thereby decreasing cholesterol saturation and promoting the dissolution of cholesterol gallstones in patients with functioning gallbladders. Additionally, it exerts cytoprotective effects on hepatocytes and cholangiocytes by stabilizing cell membranes and reducing the toxic effects of endogenous hydrophobic bile acids. Hepakind is indicated for the management of primary biliary cholangitis, intrahepatic cholestasis, and certain cases of chronic hepatitis where bile flow improvement is required. It is also utilized to prevent gallstone formation in patients undergoing rapid weight loss or bariatric surgery. The drug is administered orally, with dosage tailored according to the patient’s condition and response to therapy. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort, which are generally mild and transient. Hepakind should be used cautiously in patients with biliary obstruction or severe hepatic impairment. Regular monitoring of liver function tests is recommended during prolonged therapy to assess efficacy and detect potential adverse effects.

Dosage & How to Use